Status:

RECRUITING

The Effect of a Navigator Nurse- Supported Mobile Application Developed Based on the IMB Model on the Quality of Life of Patients With Celiac Disease

Lead Sponsor:

Ankara Yildirim Beyazıt University

Conditions:

Celiac Disease

Adults With Celiac Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This randomized controlled trial aims to evaluate the effect of a navigator nurse-supported mobile application, developed based on the Information-Motivation-Behavioral Skills (IMB) model, on the qual...

Detailed Description

Celiac disease is an autoimmune disorder characterized by gluten intolerance, leading to intestinal mucosal damage and a variety of physical and psychological symptoms. Strict adherence to a gluten-fr...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • Newly diagnosed with celiac disease
  • Owning a smartphone and able to use the application
  • Able to speak and understand Turkish
  • Voluntary participation (informed consent)

Exclusion

  • Severe gluten hypersensitivity
  • Failure to meet inclusion criteria
  • Withdrawal of consent during the study

Key Trial Info

Start Date :

August 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07177287

Start Date

August 1 2025

End Date

June 1 2026

Last Update

September 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ankara Etlik City Hospital

Ankara, Ankara, Turkey (Türkiye)